Nirmatrelvir/ritonavir as a possible treatment for Long-COVID

Rev Esp Quimioter. 2023 Oct;36(5):545-546. doi: 10.37201/req/028.2023. Epub 2023 Jun 27.
No abstract available

Keywords: COVID-19; Post-Acute COVID-19 Syndrome; SARS-CoV-2; combination; nirmaltrevir; ritonavir.

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment
  • COVID-19*
  • Humans
  • Post-Acute COVID-19 Syndrome
  • Ritonavir* / therapeutic use

Substances

  • nirmatrelvir
  • Ritonavir
  • Antiviral Agents